Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting inflammatory sites through collagen affinity enhances the therapeutic efficacy of anti-inflammatory antibodies
Authors
Keywords
-
Journal
Science Advances
Volume 5, Issue 11, Pages eaay1971
Publisher
American Association for the Advancement of Science (AAAS)
Online
2019-11-07
DOI
10.1126/sciadv.aay1971
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted antibody and cytokine cancer immunotherapies through collagen affinity
- (2019) Jun Ishihara et al. Science Translational Medicine
- Exploiting passive nanomedicine accumulation at sites of enhanced vascular permeability for non-cancerous applications
- (2017) Mikhail Durymanov et al. JOURNAL OF CONTROLLED RELEASE
- Cartilage-targeting drug delivery: can electrostatic interactions help?
- (2017) Ambika G. Bajpayee et al. Nature Reviews Rheumatology
- ACR/EULAR Definitions of Remission Are Associated with Lower Residual Inflammatory Activity Compared with DAS28 Remission on Hand MRI in Rheumatoid Arthritis
- (2016) M. P. Lisbona et al. JOURNAL OF RHEUMATOLOGY
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Ultrasound-detected tenosynovitis independently associates with patient-reported flare in patients with rheumatoid arthritis in clinical remission: results from the observational study STARTER of the Italian Society for Rheumatology
- (2016) Emanuela Bellis et al. RHEUMATOLOGY
- Design of Decorin-Based Peptides That Bind to Collagen I and their Potential as Adhesion Moieties in Biomaterials
- (2015) Stefania Federico et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Antibody-drug conjugates as novel anti-cancer chemotherapeutics
- (2015) C. Peters et al. BIOSCIENCE REPORTS
- Ado-trastuzumab Emtansine (T-DM1): An Antibody–Drug Conjugate (ADC) for HER2-Positive Breast Cancer
- (2014) John M. Lambert et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug delivery: Beyond active tumour targeting
- (2014) Sharon M. Sagnella et al. Nanomedicine-Nanotechnology Biology and Medicine
- Type-1 pericytes accumulate after tissue injury and produce collagen in an organ-dependent manner
- (2014) Alexander Birbrair et al. Stem Cell Research & Therapy
- Development of macromolecular prodrug for rheumatoid arthritis
- (2012) Fang Yuan et al. ADVANCED DRUG DELIVERY REVIEWS
- Immunocytokines: a novel class of potent armed antibodies
- (2012) Nadine Pasche et al. DRUG DISCOVERY TODAY
- Targeting the TGFβ signalling pathway in disease
- (2012) Rosemary J. Akhurst et al. NATURE REVIEWS DRUG DISCOVERY
- TGF-β signaling in fibrosis
- (2011) Anna Biernacka et al. GROWTH FACTORS
- Extracellular Matrix Proteins in Hemostasis and Thrombosis
- (2011) W. Bergmeier et al. Cold Spring Harbor Perspectives in Biology
- The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
- (2010) Jun Fang et al. ADVANCED DRUG DELIVERY REVIEWS
- Genomic phenotype of non-cultured pulmonary fibroblasts in idiopathic pulmonary fibrosis
- (2010) Margaret C. Emblom-Callahan et al. GENOMICS
- Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis
- (2010) Rebecca Anderson et al. ARTHRITIS RESEARCH & THERAPY
- The Collagen Family
- (2010) S. Ricard-Blum Cold Spring Harbor Perspectives in Biology
- Cellular and molecular mechanisms of fibrosis
- (2007) TA Wynn JOURNAL OF PATHOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started